3B BlackBio Dx (BOM:532067) Cyclically Adjusted Revenue per Share: ₹125.24 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BOM:532067 3B BlackBio Dx Ltd BOM:532067
63 GF Score
Price ₹1,262.20
GF Value ₹2,198.08
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is 3B BlackBio Dx Cyclically Adjusted Revenue per Share?

3B BlackBio Dx BOM:532067 -0.34% 63 Cyclically Adjusted Revenue per Share is ₹125.24 as of Jun. 2026. GuruFocus rates BOM:532067 with a GF Score™ of 63/100 and a GF Value™ of ₹2,198.08 (Possible Value Trap). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

3B BlackBio Dx's adjusted revenue per share for the three months ended in Jun. 2026 was ₹39.020. Add all the adjusted revenue per share for the past 10 years together and divide the count will get our Cyclically Adjusted Revenue per Share, which is ₹125.24 for the trailing ten years ended in Jun. 2026.

During the past 12 months, 3B BlackBio Dx's average Cyclically Adjusted Revenue Growth Rate was 17.90% per year. During the past 3 years, the average Cyclically Adjusted Revenue Growth Rate was 11.30% per year. During the past 5 years, the average Cyclically Adjusted Revenue Growth Rate was 10.00% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Revenue Growth Rate using Cyclically Adjusted Revenue per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Revenue Growth Rate of 3B BlackBio Dx was 11.30% per year. The lowest was 8.50% per year. And the median was 9.10% per year.

As of today (2026-08-25), 3B BlackBio Dx's current stock price is ₹1262.20. 3B BlackBio Dx's Cyclically Adjusted Revenue per Share for the quarter that ended in Jun. 2026 was ₹125.24. 3B BlackBio Dx's Cyclically Adjusted PS Ratio of today is 10.08.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of 3B BlackBio Dx was 20.97. The lowest was 3.72. And the median was 7.92.


3B BlackBio Dx  (BOM:532067) Cyclically Adjusted Revenue per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Revenue per Share may underestimate the company's revenue. Cyclically Adjusted PS Ratio can seem to be too high even the actual PS Ratio is low.

For the Cyclically Adjusted PS Ratio, the revenue per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/S calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PS Ratio is also called CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

3B BlackBio Dx's Cyclically Adjusted PS Ratio of today is calculated as

Cyclically Adjusted PS Ratio=Share Price/Cyclically Adjusted Revenue per Share
=1262.20/125.24
=10.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PS Ratio of 3B BlackBio Dx was 20.97. The lowest was 3.72. And the median was 7.92.


Be Aware

Cyclically Adjusted PS Ratio works better for cyclical companies. It gives you a better idea on the company's real revenue value.


3B BlackBio Dx Cyclically Adjusted Revenue per Share Related Terms


3B BlackBio Dx Cyclically Adjusted Revenue per Share Historical Data

* Premium members only.

The historical data trend for 3B BlackBio Dx's Cyclically Adjusted Revenue per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

3B BlackBio Dx Cyclically Adjusted Revenue per Share Chart

3B BlackBio Dx Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Cyclically Adjusted Revenue per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80.49 86.94 93.67 102.89 119.71

3B BlackBio Dx Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted Revenue per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 106.23 110.59 115.89 119.71 125.24

BOM:532067 vs VRTX, REGN, RVMD: Cyclically Adjusted Revenue per Share Comparison

For the Biotechnology subindustry, 3B BlackBio Dx's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


3B BlackBio Dx Cyclically Adjusted PS Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, 3B BlackBio Dx's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where 3B BlackBio Dx's Cyclically Adjusted PS Ratio falls into.


BOM:532067
63GF Score
3B BlackBio Dx Ltd BOM:532067
Cyclically Adjusted Revenue per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

3B BlackBio Dx Cyclically Adjusted Revenue per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Revenue per Share and the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years.

What is Cyclically Adjusted Revenue per Share? How do we calculate Cyclically Adjusted Revenue per Share?

Cyclically Adjusted Revenue per Share is the average of the inflation adjusted Revenue per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Revenue per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the revenue per share from 2001 through 2010.

We adjusted the 2001 revenue per share data with the total inflation from 2001 through 2010 to the equivalent revenue in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's revenue is $1 a share in 2001, then the 2001's equivalent revenue in 2010 is $1.4 a share. If Wal-Mart's revenue is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 revenue in 2010 is $1.35. So on and so forth, you get the equivalent revenue per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, 3B BlackBio Dx's adjusted Revenue per Share data for the three months ended in Jun. 2026 was:

Adj_RevenuePerShare= Revenue per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=39.02/167.3573*167.3573
=39.020

Current CPI (Jun. 2026) = 167.3573.

3B BlackBio Dx Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201609 9.534 105.961 15.058
201612 6.754 105.196 10.745
201703 4.680 105.196 7.445
201706 6.549 107.109 10.233
201709 12.278 109.021 18.848
201712 9.198 109.404 14.070
201803 7.646 109.786 11.655
201806 6.739 111.317 10.132
201809 10.940 115.142 15.901
201812 7.276 115.142 10.576
201903 8.477 118.202 12.002
201906 7.497 120.880 10.380
201909 12.834 123.175 17.437
201912 9.149 126.235 12.129
202003 8.978 124.705 12.049
202006 70.445 127.000 92.830
202009 170.554 130.118 219.366
202012 56.865 130.889 72.709
202103 25.149 131.771 31.941
202106 43.511 134.084 54.308
202109 23.191 135.847 28.570
202112 19.125 138.161 23.167
202203 24.506 138.822 29.543
202206 18.139 142.347 21.326
202209 19.960 144.661 23.092
202212 19.698 145.763 22.616
202303 15.371 146.865 17.516
202306 19.023 150.280 21.185
202309 21.631 151.492 23.896
202312 20.131 152.924 22.031
202403 26.795 153.035 29.303
202406 22.642 155.789 24.323
202409 34.526 157.882 36.598
202412 29.838 158.323 31.541
202503 25.126 157.552 26.690
202506 25.905 159.755 27.138
202509 40.441 162.289 41.704
202512 58.659 163.281 60.123
202603 42.426 164.272 43.223
202606 39.020 167.357 39.020

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

What does a Cyclically Adjusted Revenue per Share of ₹125.24 mean?
3B BlackBio Dx (BOM:532067) has a Cyclically Adjusted Revenue per Share of ₹125.24 as of Jun. 2026. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on 3B BlackBio Dx and its competitors.
Is 3B BlackBio Dx's Cyclically Adjusted Revenue per Share too high?
3B BlackBio Dx's current Cyclically Adjusted Revenue per Share is ₹125.24. Overall, 3B BlackBio Dx has a GF Score™ of 63/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does 3B BlackBio Dx's Cyclically Adjusted Revenue per Share compare to VRTX and REGN?
3B BlackBio Dx's Cyclically Adjusted Revenue per Share of ₹125.24 can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Revenue per Share for a Biotechnology company?
A good Cyclically Adjusted Revenue per Share depends on the Biotechnology industry context. However, Cyclically Adjusted Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Revenue per Share mean?
A high Cyclically Adjusted Revenue per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted revenue per share represents the company's inflation-adjusted revenue per share over a 10-year period. View historical data on 3B BlackBio Dx and its competitors. 3B BlackBio Dx's current Cyclically Adjusted Revenue per Share is ₹125.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is 3B BlackBio Dx stock overvalued right now?
Based on GuruFocus' analysis, 3B BlackBio Dx (BOM:532067) is currently considered Possible Value Trap. The stock's GF Value™ is ₹2,198.08, compared to a current price of ₹1,262.20 — trading 42.6% below its estimated fair value. The current Cyclically Adjusted Revenue per Share is ₹125.24. 3B BlackBio Dx's overall GF Score™ is 63/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Revenue per Share calculated?
Cyclically Adjusted Revenue per Share is calculated from a company's financial statements. For 3B BlackBio Dx (BOM:532067), the current Cyclically Adjusted Revenue per Share is ₹125.24 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is 3B BlackBio Dx (BOM:532067) Overvalued in 2026?

Based on GuruFocus' analysis, 3B BlackBio Dx stock appears to be undervalued. The current stock price of ₹1,262.20 is trading 42.6% below its estimated GF Value™ of ₹2,198.08. GuruFocus considers 3B BlackBio Dx to be Possible Value Trap.

Key valuation signals for BOM:532067:

  • Cyclically Adjusted Revenue per Share: ₹125.24
  • GF Value™: ₹2,198.08 vs. price of ₹1,262.20 (42.6% below fair value)
  • GF Score™: 63/100 with 3 warning signs

No single metric tells the full story. See the BOM:532067 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


3B BlackBio Dx Business Description

Other Exchanges 3BBLACKBIO:India
Address 7-C, Industrial Area, Govindpura, Bhopal, MP, IND, 462023
3B BlackBio Dx Ltd is an Indian company specializing in PCR-based Molecular Diagnostic Kits. The company is involved in designing, developing, manufacturing, and commercializing PCR-based Molecular Diagnostic kits, PCR Enzymes, and PCR Reagents.
63GF Score

Get the complete analysis for BOM:532067

Cyclically Adjusted Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹1,262.20
Price
₹2,198.08
GF Value